[mo_oauth_login]
Summary report
PHARMASEVEN OÜ
Date of report 19.06.2025
PHARMASEVEN OÜ
14915571 -
Deleted (28.09.2023)
Founded in
18.02.2020
Fixed capital
2,500 €
Former names
- OÜ PharmaSeven
VAT
EE102233827
(start 20.02.2020)
| start | end |
|---|---|
| 20.02.2020 | - |
keywords
PHARMASEVEN OÜ
Scores and ratings
Reputation score
0
What is Reputation score?
Credit Score
Deleted
0.03
Status 28.09.2023
Deleted
0.03
2020
year
Open the reports you want to print
Employees and salaries
PHARMASEVEN OÜ
Number of employees and estimated average salaries?
| 2022 IV | 2023 I | 2023 II | 2023 III | |
| Number of employees | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
PHARMASEVEN OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
| 2020 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
PHARMASEVEN OÜ
Former decision-makers?
Relations:
2
Turnover:
Employees:
1
Ene Solovjev
★★★★
......
Credit Score: Trustworthy
Reputation score: 350
Date of birth: ......
Active relations 2
0 followers
Relations:
1
Turnover 2025:
3 897 017 €
Employees:
12
Anastassia Izlatova
★★★★
......
Credit Score: Trustworthy
Reputation score: 2210
Date of birth: ......
Active relations 1
0 followers
PHARMASEVEN OÜ
History of right of representation?
Field
Business age
3y
Beneficial country:
et
Anastassia Izlatova
... - ...
Ene Solovjev
... - ...
2020
2021
2022
2023
2024
2025
2020
2021
2022
2023
2024
2025
PHARMASEVEN OÜ
Owners?
Former owners
PHARMASEVEN OÜ
Other related parties?
Former other persons
Other related parties (invalid relations)
| Name | Credit Score | Part | Beginning | Ending |
|---|---|---|---|---|
| ...... | ...... | ...... |
Finances and assets
PHARMASEVEN OÜ
Taxes paid and estimated average salaries| 2020 | 2021 | 2022 | 2023 | |
| National taxes | ...... | ...... | ...... | ...... |
| Labor taxes | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
PHARMASEVEN OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2023 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
PHARMASEVEN OÜ
Sales revenue by business arearevenue
| Field of activity | EMTAK code | Sales revenue (2021) | Sales revenue % |
| Pharmacies | 47731 | 534 595 € | 100,00 |
PHARMASEVEN OÜ
Financial indicators and prognosis| Financial indicators | 2021 | 2022 | 2023 Prognosis |
Trend |
| TURNOVER | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Other countries | ...... | ...... | ...... | |
| INTEREST INCOME | ...... | ...... | ...... | |
| OTHER BUSINESS INCOME | ...... | ...... | ...... | |
| TURNOVER IN RELATED COMPANY | ...... | ...... | ...... | |
| AVERAGE MONTHLY TURNOVER | ...... | ...... | ...... | |
| Available credit (credit limit) | ...... | ...... | ...... | |
| Settlement dates | ...... | ...... | ...... | |
| RECEIVED GRANTS € | ...... | ...... | ...... | |
| TENDERS WON € | ...... | ...... | ...... | |
| ASSETS | ...... | ...... | ...... | |
| Current assets | ...... | ...... | ...... | |
| Fixed assets | ...... | ...... | ...... | |
| LIABILITIES | ...... | ...... | ...... | |
| Short-term liabilities | ...... | ...... | ...... | |
| Long-term liabilities | ...... | ...... | ...... | |
| EQUITY | ...... | ...... | ...... | |
| Share-(equity capital) | ...... | ...... | ...... | |
| Retained profits | ...... | ...... | ...... | |
| Net profit | ...... | ...... | ...... | |
| NET WORKING CAPITAL | ...... | ...... | ...... | |
| NUMBER OF EMPLOYEES | ...... | ...... | ...... |
PHARMASEVEN OÜ
Financial raiting: "SATISFACTORY" (2023 prognosis)| Multipliers and income levels | 2022 | 2023 prognosis |
Trend |
| LIQUIDITY | ...... | ...... | |
| Net Working capital | ...... | ...... | |
| Short-term debt coverage ratio (X) | ...... | ...... | |
| EFFECTIVENESS | ...... | ...... | |
| Debt to assets ratio (X) | ...... | ...... | |
| Capitalisation multiplier (X) | ...... | ...... | |
| USE OF LOAN CAPITAL | ...... | ...... | |
| Turnover ratio of fixed assets (X) | ...... | ...... | |
| PROFITABILITY | ...... | ...... | |
| Sales revenues (%) | ...... | ...... | |
| Total asset revenues (%) | ...... | ...... | |
| Equity revenues (%) | ...... | ...... |
2023 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
PHARMASEVEN OÜ
Annual reportsLiabilities and debts
PHARMASEVEN OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral
Borderline
Problematic
Risky
PHARMASEVEN OÜ
Reports and assets-liabilities overview 28.09.2023?
Annual reports:
......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
PHARMASEVEN OÜ
Claims history?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
PHARMASEVEN OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2023 III | ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
PHARMASEVEN OÜ
Bailiff's enforcement proceedings as of 28.09.2023?
Bailiff's enforcement proceedings MISSING
PHARMASEVEN OÜ
Regulations of the Payment Order Department as of 28.09.2023?
Regulations of the Payment Order Department MISSING
PHARMASEVEN OÜ
Court orders in the register as of 28.09.2023?
Puuduste kõrvaldamise määrus
15.09.2023
Regulation number: Ä 50140288 / M1
Regulation status has entered into force: 15.09.2023
Regulation status: Allkirjastatud
PHARMASEVEN OÜ
Decisions of the Consumer Disputes Committee as of 28.09.2023?
Consumer disputes MISSING
PHARMASEVEN OÜ
Court hearings as of 28.09.2023?
Number of the case: 2-20-14136
Harju Maakohus Tallinna kohtumaja
03.05.2021
Status of the hearing:
Tühistatud
| Chamber: | kohtusaal nr 4003 |
| Judge: | Anu Uritam |
| Description of hearings: | ...... |
PHARMASEVEN OÜ
Rulings as of 28.09.2023?
Kohtumäärus tsiviilasjas nr 2-20-14255/19
Tallinna Ringkonnakohtu tsiviilkolleegium
26.02.2021
| Related companies: | |
| Number of the case: | 2-20-14255/19 |
| Type of procedure: | Tsiviilasi |
| Court: | Tallinna Ringkonnakohtu tsiviilkolleegium |
| Type of solution: | Kohtumäärus |
| Solution subcategory: | - |
| Composition of the Court: | Peeter Pällin, Margo Klaar, Ele Liiv |
| Commencement of the Court case: | 30.09.2020 |
| Type of procedure: | Määruskaebusmenetlus |
| Commencement of proceedings: | 10.12.2020 |
| Court case category: | Võlaõigus |
| Keyword: | - |
| Court decision date: | 26.02.2021 |
| Entry into force: | 19.03.2021 |
| Dissenting opinion: | |
| ECLI identifier: ? |
ECLI:EE:TLRK:2021:2.20.14255.3405 |
PHARMASEVEN OÜ
Notices and announcements as of 28.09.2023?
Notice of merger
29.09.2023
Äriühingu ühinemise teade
Avaldamise algus: 29.09.2023
Avaldamise lõpp: tähtajatu
Avaldamise lõpp: tähtajatu
OÜ PharmaOne (registrikood 14435764) avaldab teadaande äriseadustiku (ÄS) § 399 lõike 1 alusel.
Ühing teatab ühinemisest. Ühinemisel osalesid OÜ PharmaOne (registrikood 14435764) ja OÜ PharmaSeven (registrikood: 14915571), asukoht: Akadeemia tee 45, Tallinn. Osaühing PharmaOne (ühendav ühing) ühendab endaga äriühingu OÜ PharmaSeven (ühendatav ühing).
Äriühingute võlausaldajatel palume esitada oma nõuded tagatise saamiseks kuue kuu jooksul käesoleva teate avaldamisest (ÄS § 399 lg 1). pharmaone@mail.ee
Robert Tiis
Ühing teatab ühinemisest. Ühinemisel osalesid OÜ PharmaOne (registrikood 14435764) ja OÜ PharmaSeven (registrikood: 14915571), asukoht: Akadeemia tee 45, Tallinn. Osaühing PharmaOne (ühendav ühing) ühendab endaga äriühingu OÜ PharmaSeven (ühendatav ühing).
Äriühingute võlausaldajatel palume esitada oma nõuded tagatise saamiseks kuue kuu jooksul käesoleva teate avaldamisest (ÄS § 399 lg 1). pharmaone@mail.ee
Robert Tiis
Ärinimed
OÜ PharmaOne, kehtetud ärinimed: OÜ PharmaÜks.
OÜ PharmaOne
Tartu linn, Tartu linn, Tartu maakond, F. Tuglase tn 19
E-post: pharmaone@mail.ee
Tartu linn, Tartu linn, Tartu maakond, F. Tuglase tn 19
E-post: pharmaone@mail.ee
Teadaande number 2128319
Marketing
Business network
PHARMASEVEN OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
PHARMASEVEN OÜ
Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.